Search

everythinglearnresearchcommunity

for

Search:↓

UV radiation may cause DNA changes in skin, certain UVB therapy helps psoriasis, a new gene mutation is linked to mild piebaldism, different immune cells affect psoriasis, a drug promotes hair growth, and some cancer drugs could treat skin barrier issues.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

The Multi-Organ-Chip improves the growth and quality of skin and hair in the lab, potentially replacing animal testing.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Stress increases nerve fibers and immune cell activity in mouse skin, possibly worsening skin conditions.

Nerves and chemicals in the body can affect hair growth and loss.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Fibroblasts, cells usually linked to tissue repair, also help regenerate various organs and their ability decreases with age. Turning adult fibroblasts back to a younger state could be a new treatment approach.

Platelet-Rich Plasma (PRP) therapy can promote hair growth and improve facial aesthetics, including reducing acne scars and facial burns, and it works best with three initial monthly injections.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.

Higher Claudin 3 levels in the blood are linked to more severe alopecia areata.

Not having enough cystatin M/E protein causes less hair growth and dry skin.

Differences in growth factors in platelet-rich plasma therapy for hair loss can vary between patients and can be influenced by the devices used, possibly leading to inconsistent results.

New materials and methods could improve skin healing and reduce scarring.

Cyclosporine starts hair growth faster, while minoxidil makes it last longer.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

Human skin can make serotonin and melatonin, which help protect and maintain it.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Biomaterials with MSC-derived substances could improve tissue repair and have advantages over direct cell therapy.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

The conclusion is that tissue structure is key for stem cell communication and maintaining healthy tissues.

Drosha and Dicer are essential for hair follicle health and preventing DNA damage in skin cells.